StonvexLoading…
StonvexStonvexStonvexCore line items from HNI's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Annual 2026 2026-01-03 | Annual 2024 2024-12-28 | Annual 2023 2023-12-30 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $2.84B | $2.53B | $2.43B | $2.36B |
Operating Income | $126.00M | $206.50M | $90.30M | $155.20M |
Net Income | $54.20M | $139.50M | $49.20M | $123.90M |
EPS (Diluted) | $1.11 | $2.88 | $1.09 | $2.94 |
Total Assets | $4.88B | $1.88B | $1.93B | $1.41B |
Total Liabilities | $3.05B | $1.03B | $1.17B | Not available |
Cash & Equivalents | $209.20M | $20.20M | $28.90M | $17.40M |
Free Cash Flow OCF − CapEx | $208.50M | $173.80M | $188.40M | $12.80M |
Shares Outstanding | 71.30M | 47.20M | 46.90M | 41.40M |